High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis

References

• ColemanMPCancer survival: global surveillance will stimulate health policy and improve equityLancet2014383991656457324351320
   PubMed Web of Science ®Google Scholar
• AllemaniCWeirHKCarreiraHGlobal surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)Lancet20153859972977101025467588
   PubMed Web of Science ®Google Scholar
• Reyes-TurcuFEVentiiKHWilkinsonKDRegulation and cellular roles of ubiquitin-specific deubiquitinating enzymesAnnu Rev Biochem20097836339719489724
   PubMed Web of Science ®Google Scholar
• HoellerDDikicITargeting the ubiquitin system in cancer therapyNature2009458723743844419325623
   PubMed Web of Science ®Google Scholar
• LoveKRCaticASchliekerCPloeghHLMechanisms, biology and inhibitors of deubiquitinating enzymesNat Chem Biol200731169770517948018
   PubMed Web of Science ®Google Scholar
• ZhangXYVarthiMSykesSMThe putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progressionMol Cell200829110211118206973
   PubMed Web of Science ®Google Scholar
• ArmourSMBennettEJBraunCRA high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complexMol Cell Biol20133381487150223382074
   PubMed Web of Science ®Google Scholar
• GlinskyGVBerezovskaOGlinskiiABMicroarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancerJ Clin Invest200511561503152115931389
   PubMed Web of Science ®Google Scholar
• GlinskyGV“Stemness” genomics law governs clinical behavior of human cancer: implications for decision making in disease managementJ Clin Oncol200826172846285318539963
   PubMed Web of Science ®Google Scholar
• GlinskyGVGenomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathwayCell Cycle20065111208121616760651
   PubMed Web of Science ®Google Scholar
• LiuYYangYXuHDongXImplication of USP22 in the regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and cyclin D2 expression in primary colorectal carcinomasDiagn Mol Pathol201019419420021052002
   PubMedGoogle Scholar
• LinZYangHKongQUSP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic developmentMol Cell201246448449422542455
   PubMed Web of Science ®Google Scholar
• NingZWangALiangJUSP22 promotes the G1/S phase transition by upregulating FoxM1 expression via beta-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinomaInt J Oncol20144541594160824993031
   PubMed Web of Science ®Google Scholar
• ZhangJLuoNTianYUSP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of AktOncotarget2017815247282474028445968
   PubMedGoogle Scholar
• LvLXiaoXYGuZHZengFQHuangLQJiangGSSilencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cellsMol Cell Biochem20113461–2112120824490
   PubMed Web of Science ®Google Scholar
• KimDHongAParkHIDeubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cellsJ Cell Physiol2017232123664367628160502
   PubMed Web of Science ®Google Scholar
• LiYYangYLiJUSP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4Oncotarget2017820326833269528427243
   PubMedGoogle Scholar
• LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJ Clin Epidemiol20096210e1e3419631507
   PubMed Web of Science ®Google Scholar
• OremusMOremusCHallGBMcKinnonMCECT & Cognition Systematic Review TeamInter-rater and test-retest reliability of quality assessments by novice student raters using the Jadad and Newcastle-Ottawa ScalesBMJ Open201224 pii:e001368
   Web of Science ®Google Scholar
• LiJWangZLiYUSP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinomaJ Cancer Res Clin Oncol201213881291129722447106
   PubMed Web of Science ®Google Scholar
• PiaoSMaJWangWIncreased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinomaOral Oncol201349879680123664741
   PubMed Web of Science ®Google Scholar
• YangDDCuiBBSunLYThe co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinomaCell Biochem Biophys201161370371021735131
   PubMed Web of Science ®Google Scholar
• LiuYLYangYMXuHDongXSAberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancerJ Surg Oncol2011103328328921337558
   PubMed Web of Science ®Google Scholar
• HuJYangDZhangHUSP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinomaLung Cancer201588323924525907317
   PubMed Web of Science ®Google Scholar
• WangZZhuLGuoTWangYYangJDecreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinomaHum Pathol20154671006101425971547
   PubMed Web of Science ®Google Scholar
• YangMLiuYDWangYYLiuTBGeTTLouGUbiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeuticsTumour Biol201435292993423979981
   PubMedGoogle Scholar
• ZhangYYaoLZhangXElevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancerJ Cancer Res Clin Oncol201113781245125321691749
   PubMed Web of Science ®Google Scholar
• LiangJZhangXXieSUbiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeuticsMed Oncol201431489924573640
   PubMed Web of Science ®Google Scholar
• WangHLiYPChenJHPrognostic significance of USP22 as an oncogene in papillary thyroid carcinomaTumour Biol20133431635163923412977
   PubMedGoogle Scholar
• NingJZhangJLiuWLangYXueYXuSOverexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancerEur J Histochem2012564e4623361242
   PubMed Web of Science ®Google Scholar
• TangBLiangXTangFExpression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinomaInt J Oncol20154762208221626497847
   PubMed Web of Science ®Google Scholar
• LiuYLYangYMXuHDongXSIncreased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancerJ Gastroenterol Hepatol201025111800180521039844
   PubMed Web of Science ®Google Scholar
• TangBTangFLiBHigh USP22 expression indicates poor prognosis in hepatocellular carcinomaOncotarget2015614126541266725909224
   PubMedGoogle Scholar
• ZhaoHDTangHLLiuNNTargeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinomaOncotarget2016721311913120327145278
   PubMedGoogle Scholar
• LiangJXNingZGaoWUbiquitin-specific protease 22 induced autophagy is correlated with poor prognosis of pancreatic cancerOncol Rep20143262726273425241857
   PubMed Web of Science ®Google Scholar
• PiaoSLiuYHuJUSP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinomaPLoS One201278e4254022880026
   PubMed Web of Science ®Google Scholar
• DaiWYaoYZhouQSunCFUbiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinomaPLoS One201491e8714824466336
   PubMed Web of Science ®Google Scholar
• KarapanagiotouEMTerposEDilanaKDSerum bone turnover markers may be involved in the metastatic potential of lung cancer patientsMed Oncol201027233233819373566
   PubMed Web of Science ®Google Scholar
• LeQTChenESalimAAn evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancersClin Cancer Res20061251507151416533775
   PubMed Web of Science ®Google Scholar
• FeinbergAPTyckoBThe history of cancer epigeneticsNat Rev Cancer20044214315314732866
   PubMed Web of Science ®Google Scholar
• AtanassovBSDentSYUSP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1EMBO Rep201112992493021779003
   PubMed Web of Science ®Google Scholar
• PijnappelWWTimmersHTDubbing SAGA unveils new epigenetic crosstalkMol Cell200829215215418243109
   PubMed Web of Science ®Google Scholar
• ChipumuroEHenriksenMAThe ubiquitin hydrolase USP22 contributes to 3′-end processing of JAK-STAT-inducible genesFASEB J201226284285422067483
   PubMed Web of Science ®Google Scholar
• BergerSLThe complex language of chromatin regulation during transcriptionNature2007447714340741217522673
   PubMed Web of Science ®Google Scholar
• BouchardCDittrichOKiermaierARegulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoterGenes Dev200115162042204711511535
   PubMed Web of Science ®Google Scholar
• GuneyIWuSSedivyJMReduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a)Proc Natl Acad Sci U S A2006103103645365016537449
   PubMed Web of Science ®Google Scholar